Global-E-Care SRL
3.5 FTEThe score of Global-E-Care shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -6 % Headcount (avg FTE) +17 %
Accounts of the company itself (not consolidated).
The full file covers 8 financial years; a free account shows 2. →Global-E-Care's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 175,699 € | ||||
| Equity | −115,614 € | ||||
| Cash | 96,554 € | ||||
| EBITDA | 336,717 € | ||||
| Total assets | €1.41m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 20 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 06 Jul 2023
- Year ended 31 Dec 2021filed on 01 Aug 2022
Global-E-Care's financial analysis
- Solvency-8.2%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Global-E-Care
Global-E-Care's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0821.138.751
- VAT number
- BE0821138751
- Peppol
- Registered · 0208:0821138751 · as of 28 Oct 2026
- Legal form
- SRL
- Incorporated
- 04 Dec 2009
- Registered office
- 2000 Antwerp
- Size
- Micro · 3.5 FTE
- Latest accounts
- 2025 · filed on 20 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Global-E-Care (SRL) has been based in Antwerp since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 175,699 € and equity of −115,614 €; its revenue is not published. With 3.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -8.2%, below the median of its sector (44.2%).
Companies similar to Global-E-Care
Companies in the same business, of comparable size and area, outside its group.
- Apharmat Retail sale of pharmaceutical products Antwerp · balance sheet €1.42m
- Vanlerberghe Invest Retail sale of pharmaceutical products Torhout · balance sheet €1.38m
- Herseltpharma Retail sale of pharmaceutical products Herselt · balance sheet €1.31m
- Pharmacie Stassen-BYA Retail sale of pharmaceutical products Juprelle · balance sheet €1.18m
- Management Lormans-Bekkers Retail sale of pharmaceutical products Beringen · balance sheet €1.84m
- Apotheek Sempels Retail sale of pharmaceutical products Grobbendonk · balance sheet €1.88m
- Benepharma Retail sale of pharmaceutical products Overijse · balance sheet 813,930 €
- Lavista Pharma Retail sale of pharmaceutical products Courcelles · balance sheet €2.47m
Frequently asked questions about Global-E-Care
What is the revenue of Global-E-Care?
Global-E-Care files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Global-E-Care?
In Belgium, the VAT number is the company number prefixed with BE: BE0821138751 for Global-E-Care, if the company is VAT-registered. Its company number (CBE) is 0821.138.751.
Where is the registered office of Global-E-Care?
According to the CBE register, the registered office of Global-E-Care is in 2000 Antwerp.
What is the equity of Global-E-Care?
At the close of the 2025 financial year, the equity of Global-E-Care amounts to -115,614 €, a solvency of -8.2% of total assets.
How many people work at Global-E-Care?
3.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Global-E-Care?
The register lists 3 active mandates at Global-E-Care. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Global-E-Care
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →